Oxidative stress and altered expression of peroxiredoxin genes family (PRDXS) and sulfiredoxin-1 (SRXN1) in human lung tissue following exposure to sulfur mustard

Experimental Lung Research

Volumn 42, Issue 4, 2016, Pages 217-226

  Tahmasbpour Marzony, Eisa ^a   Ghanei, Mostafa ^a   Panahi, Yunes ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lung; Malondialdehyde; Oxidative stress; Peroxiredoxins; Protein carbonyl; Sulfiredoxin 1; Sulfur mustard

Indexed keywords

BIOLOGICAL MARKER; MUSTARD GAS; OXIDOREDUCTASE; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 3; PEROXIREDOXIN 4; PEROXIREDOXIN 5; PEROXIREDOXIN 6; REACTIVE OXYGEN METABOLITE; SULFIREDOXIN 1; UNCLASSIFIED DRUG; MALONALDEHYDE; PRDX1 PROTEIN, HUMAN; SRXN1 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG LAVAGE; LUNG PARENCHYMA; OXIDATIVE STRESS; PEROXIREDOXIN 1 GENE; PEROXIREDOXIN 2 GENE; PEROXIREDOXIN 3 GENE; PEROXIREDOXIN 4 GENE; PEROXIREDOXIN 5 GENE; PEROXIREDOXIN 6 GENE; PEROXIREDOXIN GENE; PRIORITY JOURNAL; SULFIREDOXIN 1 GENE; UPREGULATION; VITAL CAPACITY; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CASE CONTROL STUDY; CHEMISTRY; DRUG EFFECTS; GENETICS; LUNG; METABOLISM; PATHOLOGY; PROTEIN CARBONYLATION;

BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CASE-CONTROL STUDIES; HUMANS; LUNG; MALONDIALDEHYDE; MUSTARD GAS; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON SULFUR GROUP DONORS; PEROXIREDOXINS; PROTEIN CARBONYLATION; REACTIVE OXYGEN SPECIES; UP-REGULATION;

EID: 84973661578     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.1080/01902148.2016.1194501     Document Type: Article

References (32)

1. A.Najafi, A.Masoudi-Nejad, A.A.Imani Fooladi, M.Ghanei, M.R.Nourani. Microarray gene expression analysis of the human airway in patients exposed to sulfur mustard. J Recept Signal Transduct Res. 2014;34(4):283–289.
2. E.Tahmasbpour, S.Reza Emami, M.Ghanei, Y.Panahi. Role of oxidative stress in sulfur mustard-induced pulmonary injury and antioxidant protection. Inhal Toxicol. 2015;1–14.
3. M.R.Nourani, S.Azimzadeh, M.Ghanei, A.A.Imani Fooladi. Expression of glutathione S-transferase variants in human airway wall after long-term response to sulfur mustard. J Recept Signal Transduct Res. 2014;34(2):125–130.
4. J.Beheshti, E.J.Mark, H.M.Akbaei, J.Aslani, M.Ghanei. Mustard lung secrets: long term clinicopathological study following mustard gas exposure. Pathol Res Pract. 2006;202(10):739–744.
5. M.Ghanei, A.A.Harandi. Molecular and cellular mechanism of lung injuries due to exposure to sulfur mustard: a review. Inhal Toxicol. 2011;23(7):363–371.
6. E.Tahmasbpour, M.Ghanei, Y.Panahi. Relationship of oxidative stress with male infertility in sulfur mustard-exposed injuries. Asian Pacific J Reprod. 2016;5(1):1–9.
7. Y.Liang Zhu, E.A.Pilon-Smits, L.Jouanin, N.Terry. Overexpression of glutathione synthetase in Indian mustard enhances cadmium accumulation and tolerance. Plant Physiol. 1999;119(1):73–80.
8. M.Shohrati, M.Ghanei, N.Shamspour, F.Babaei, M.N.Abadi, M.Jafari, et al. Glutathione and malondialdehyde levels in late pulmonary complications of sulfur mustard intoxication. Lung 2010;188(1):77–83.
9. T.M.Shuvaeva, V.I.Novoselov, E.E.Fesenko, V.M.Lipkin. Peroxiredoxins, a new family of antioxidant proteins. Bioorg Khimiia 2009;35(5):581–596.
10. S.G.Rhee, S.W.Kang, T.S.Chang, W.Jeong, K.Kim. Peroxiredoxin, a novel family of peroxidases. IUBMB Life 2001;52(1-2):35–41.
11. M.K.Cha, K.H.Suh, I.H.Kim. Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma. J Exp Clin Cancer Res: CR. 2009;28:93.
12. L.Nonn, M.Berggren, G.Powis. Increased expression of mitochondrial peroxiredoxin-3 (thioredoxin peroxidase-2) protects cancer cells against hypoxia and drug-induced hydrogen peroxide-dependent apoptosis. Molecular Cancer Res. 2003;1(9):682–689.
13. R.E.Martin, Z.Cao, N.J.Bulleid. Regulating the level of intracellular hydrogen peroxide: the role of peroxiredoxin IV. Biochem Soc Trans. 2014;42(1):42–46.
14. A.Kropotov, N.Usmanova, V.Serikov, B.Zhivotovsky, N.Tomilin. Mitochondrial targeting of human peroxiredoxin V protein and regulation of PRDX5 gene expression by nuclear transcription factors controlling biogenesis of mitochondria. FEBS J. 2007;274(22):5804–5814.
15. A.A.Asuni, M.Guridi, S.Sanchez, M.J.Sadowski. Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo. Neurochem Int. 2015;90:152–165.
16. 2. J Biol Chem. 2012;287(1):81–89.
17. R.L.Levine, J.A.Williams, E.R.Stadtman, E.Shacter. Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 1994;233:346–357.
18. R.L.Levine, D.Garland, C.N.Oliver, A.Amici, I.Climent, A.G.Lenz, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 1990;186:464–478.
19. B.Rao, J.C.Soufir, M.Martin, G.David. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Res. 1989;24(2):127–134.
20. E.Tahmasbpour, M.Ghanei, A.Qazvini, E.Vahedi, Y.Panahi. Gene expression profile of oxidative stress and antioxidant defense in lung tissue of patients exposed to sulfur mustard. Mutat Res/Genet Toxicol Environ Mutagen. 2016;800-801:12–21.
21. L.Mirbagheri, M.Habibi Roudkenar, A.A.Imani Fooladi, M.Ghanei, M.R.Nourani. Downregulation of super oxide dismutase level in protein might be due to sulfur mustard induced toxicity in lung. Iranian J Allergy, Asthma, Immunol. 2013;12(2):153–160.
22. S.G.Rhee, H.A.Woo, I.S.Kil, S.H.Bae. Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides. J Biol Chem. 2012;287(7):4403–4410.
23. M.X.Wang, A.Wei, J.Yuan, A.Clippe, A.Bernard, B.Knoops, et al. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem Biophys Res Commun. 2001;284(3):667–673.
24. M.S.Seo, S.W.Kang, K.Kim, I.C.Baines, T.H.Lee, S.G.Rhee. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J Biol Chem. 2000;275(27):20346–20354.
25. D.Y.Noh, S.J.Ahn, R.A.Lee, S.W.Kim, I.A.Park, H.Z.Chae. Overexpression of peroxiredoxin in human breast cancer. Anticancer Res. 2001;21(3B):2085–2090.
26. T.Yanagawa, T.Ishikawa, T.Ishii, K.Tabuchi, S.Iwasa, S.Bannai, et al. Peroxiredoxin I expression in human thyroid tumors. Cancer Lett. 1999;145(1-2):127–132.
27. V.L.Kinnula, S.Lehtonen, R.Sormunen, R.Kaarteenaho-Wiik, S.W.Kang, S.G.Rhee, et al. Overexpression of peroxiredoxins I, II, III, V, and VI in malignant mesothelioma. J Pathol. 2002;196(3):316–323.
28. J.W.Chang, H.B.Jeon, J.H.Lee, J.S.Yoo, J.S.Chun, J.H.Kim, et al. Augmented expression of peroxiredoxin I in lung cancer. Biochem Biophys Res Commun. 2001;289(2):507–12.
29. H.C.Whitaker, D.Patel, W.J.Howat, A.Y.Warren, J.D.Kay, T.Sangan, et al. Peroxiredoxin-3 is overexpressed in prostate cancer and promotes cancer cell survival by protecting cells from oxidative stress. Br J Cancer. 2013;109(4):983–993.
30. R.Ummanni, F.Barreto, S.Venz, C.Scharf, C.Barett, H.A.Mannsperger, et al. Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro. J Prot Res. 2012;11(4):2452–2466.
31. D.ChunlingDong, L.BoLi, Y.DongYang, W.GuifangWang, W.XiangdongWang, C.Bai. Overexpression of peroxiredoxin 6 protect mice from ovalbumin-induced airway inflammation and hypersecretion of MUC5AC by reducing ROS levels. Eur Respir Soc. 2014;38:Suppl 55.
32. A.Ramesh, S.S.Varghese, J.Doraiswamy, S.Malaiappan. Role of sulfiredoxin in systemic diseases influenced by oxidative stress. Redox Biol. 2014;2C:1023–1028.